New cancer clinical trial: Atezolizumab + Stereotactic Radiosurgery in Triple-negative Breast Cancer and Brain Metastasis

Published on: March 29, 2018 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Atezolizumab;   Procedure: Stereotactic radiosurgery (SRS)
Sponsors:   Dana-Farber Cancer Institute;   Genentech, Inc.
Not yet recruiting
https://ift.tt/2GKjwOs